Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease

1

Review clinical trials related to Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

This study will evaluate the safety, tolerability, preliminary efficacy and pharmacokinetics (PK) of ART5803 in adult participants with a confirmed diagnosis of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis (ANRE) or anti-NMDAR autoantibody-associated psychiatric disease

Participants needed: 30
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Arialys Australia Pty LtdUpdated: May 12, 2026Locations: 1
Eligibility criteria

The participant is a male or female who is of legal age to provide informed cons... [+53]